APA

Marquez V. E., Nacro K., Benzaria S., Lee J., Sharma R., Teng K., Milne G. W., Bienfait B., Wang S., Lewin N. E. & Blumberg P. M. (19991026). The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. : Pharmacology & therapeutics.

Chicago

Marquez V E, Nacro K, Benzaria S, Lee J, Sharma R, Teng K, Milne G W, Bienfait B, Wang S, Lewin N E and Blumberg P M. 19991026. The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. : Pharmacology & therapeutics.

Harvard

Marquez V. E., Nacro K., Benzaria S., Lee J., Sharma R., Teng K., Milne G. W., Bienfait B., Wang S., Lewin N. E. and Blumberg P. M. (19991026). The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. : Pharmacology & therapeutics.

MLA

Marquez V E, Nacro K, Benzaria S, Lee J, Sharma R, Teng K, Milne G W, Bienfait B, Wang S, Lewin N E and Blumberg P M. The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. : Pharmacology & therapeutics. 19991026.